ADCT ADC Therapeutics Corp: Bathi resik saben siji saham sajrone rolas wulan pungkasan

Logo perusahaan publik ADC Therapeutics S.A. (ADCT)

ADC Therapeutics (ADCT) develops advanced molecules for the targeted destruction of blood tumors, offering patients a gentler alternative to traditional treatment. However, high promotion and R&D expenses leave the company deeply unprofitable, hindering the creation of a sustainable cash flow. This chart on GURU.Markets shows EPS at 63.10, while patent protection and strict FDA requirements create a powerful barrier to entry for new players.

ADC Therapeutics S.A. (ADCT): Bathi resik saben saham (EPS TTM) saka 11.02.2024 nganti 17.11.2026

ADC Therapeutics SA - rincian analitis lan metrik utama (ADCT)

- rega saham lan prakiraan rega para ahli:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:ADC Therapeutics
Produk seri adctherapeutics.com

ADC Therapeutics relies on the commercialization of an innovative conjugate for lymphoma therapy. By analyzing the annual percentage growth of EPS TTM, an investor tracks the rate of change in net income per share over a rolling year. This metric measures the efficiency of converting revenue into shareholder value, neutralizing short-term quarterly fluctuations. A stable trajectory for this indicator confirms the resilience of the operating model within the biotechnological cycle.